Beyond just peptide antigens: the complex world of peptide-based cancer vaccines
Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune response to elicit its effector function. They have shown to be highly specific and safe, but have yet to prove themselves as an efficacious treatment for cancer in the clinic. This is for a variety of reasons, incl...
Main Authors: | Stephens, AJ, Burgess-Brown, NA, Jiang, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Frontiers Media
2021
|
Títulos similares
-
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
por: Alexander J. Stephens, et al.
Publicado: (2021-06-01) -
Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
por: Xiao Wei, et al.
Publicado: (2019-05-01) -
Adrenomedullin: Not Just Another Gastrointestinal Peptide
por: Sonia Martínez-Herrero, et al.
Publicado: (2022-01-01) -
Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
por: Jennifer Pfeil, et al.
Publicado: (2021-08-01) -
Peptide Vaccines for Cancer
por: Kono K
Publicado: (2013-10-01)